StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
51
This year
6
Publishing Date
2024 - 03 - 15
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2024 - 02 - 06
1
2024 - 02 - 02
1
2024 - 01 - 26
1
2023 - 12 - 08
1
2023 - 11 - 06
1
2023 - 11 - 02
1
2023 - 09 - 20
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 08
1
2023 - 06 - 01
1
2023 - 05 - 26
1
2023 - 05 - 15
1
2023 - 05 - 10
1
2023 - 04 - 27
1
2023 - 04 - 07
1
2023 - 02 - 24
1
2023 - 02 - 16
1
2023 - 02 - 07
1
2023 - 01 - 19
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 06
1
2022 - 12 - 15
1
2022 - 11 - 01
1
2022 - 10 - 19
1
2022 - 09 - 13
1
2022 - 09 - 07
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 08 - 02
1
2022 - 07 - 20
1
2022 - 07 - 13
1
2022 - 06 - 24
1
2022 - 06 - 02
1
2022 - 05 - 26
1
2022 - 05 - 17
1
2022 - 05 - 09
2
2022 - 04 - 12
1
2022 - 03 - 21
1
2022 - 03 - 16
1
2021 - 11 - 12
1
2021 - 11 - 02
1
2021 - 10 - 07
1
2021 - 10 - 04
1
Sector
Health technology
51
Manufacturing
13
N/a
2
Professional, scientific, and technical services
1
Tags
Alzheimer's
1
Alzheimer’s
1
Antibody
3
Biocapital
1
Blood
1
Business
2
Cancer
7
Cell
1
Covid-19
1
Diabetes
1
Diagnostics
1
Disease
8
Drug
5
Earnings
4
Events
1
Expansion
1
Expected
2
Financial
2
Financial results
1
Global
15
Growing
2
Growth
9
Life
1
Liver
1
Lung
1
Lupus
1
Market
35
Meeting
1
Metabolic
1
N/a
45
Opioid
1
Orphan drug
1
Presentation
1
Rare
1
Reach
3
Report
18
Research
7
Results
3
Study
1
System
1
Therapeutics
7
Therapy
3
Treat
1
Treatment
12
Ulcerative colitis
2
Entities
3m company
8
Abbott laboratories
105
Abbvie inc.
218
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
12
Alcon inc.
14
Alkermes plc
7
Amgen inc.
168
Astellas pharma inc
70
Astrazeneca plc
171
Autolus therapeutics plc
7
Bausch health companies inc.
61
Baxter international inc.
45
Becton, dickinson and company
17
Beigene, ltd.
7
Biogen inc.
47
Biomarin pharmaceutical inc.
6
Biontech se
9
Boston scientific corporation
13
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
82
Chinook therapeutics, inc.
7
Csl ltd
9
Danaher corporation
10
Eli lilly and company
121
Endo international plc
20
General electric company
8
Genmab a/s
12
Gilead sciences, inc.
25
Glaxosmithkline plc
264
Grifols sa
10
Incyte corporation
15
Ionis pharmaceuticals, inc.
7
Jazz pharmaceuticals plc
13
Johnson & johnson
189
Koninklijke philips n.v.
17
Mallinckrodt plc
17
Medtronic plc
29
Morphosys ag
12
Novartis ag
1031
Novo nordisk a/s
27
Orange
8
Orchard therapeutics plc
8
Perrigo company
7
Pfizer, inc.
68
Precision biosciences, inc.
8
Reckitt benckiser group plc
9
Regeneron pharmaceuticals, inc.
12
Regenxbio inc.
11
Sanofi
284
Smith & nephew plc
7
Stryker corporation
10
Takeda pharmaceutical company limited
51
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
48
Ucb s.a.
8
Viatris inc.
115
Xencor, inc.
9
Symbols
ABBV
31
ABT
10
ADMA
4
ALPMF
12
ALPMY
12
AMGN
23
ARCT
26
ARWR
12
AZN
29
AZNCF
27
BAX
5
BHC
7
BIIB
6
BMY
43
CDXS
3
CMXHF
4
CNTG
5
CSLLY
4
CTLT
3
EXEL
27
FNCTF
4
GBT
3
GILD
15
GLAXF
29
GMAB
3
GRFS
6
GSK
34
HCM
7
INCY
16
JAZZ
6
JNJ
82
KPTI
7
LLY
42
LOGC
4
MGNX
4
MNK
4
MNKKQ
4
MNKPF
4
MOR
13
MPSYF
11
MRNA
5
NBIX
9
NVAX
4
NVO
15
NVS
58
NVSEF
51
OVID
6
PFE
23
REGN
6
SNY
60
SNYNF
51
TAK
421
TEVA
5
TEVJF
20
TMO
7
UCBJF
8
UCBJY
8
VRTX
4
VTRS
7
XNCR
12
Exchanges
Nasdaq
51
Nyse
51
Crawled Date
2024 - 03 - 15
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2024 - 02 - 07
1
2024 - 02 - 02
1
2024 - 01 - 26
1
2023 - 12 - 08
1
2023 - 11 - 06
1
2023 - 11 - 02
1
2023 - 09 - 21
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 08
1
2023 - 06 - 01
1
2023 - 05 - 27
1
2023 - 05 - 15
1
2023 - 05 - 10
1
2023 - 04 - 28
1
2023 - 04 - 07
1
2023 - 02 - 24
1
2023 - 02 - 16
1
2023 - 02 - 07
1
2023 - 01 - 19
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 06
1
2022 - 12 - 15
1
2022 - 11 - 01
1
2022 - 10 - 19
1
2022 - 09 - 13
1
2022 - 09 - 07
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 08 - 02
1
2022 - 07 - 20
1
2022 - 07 - 13
1
2022 - 06 - 24
1
2022 - 06 - 02
1
2022 - 05 - 26
1
2022 - 05 - 17
1
2022 - 05 - 09
2
2022 - 04 - 12
1
2022 - 03 - 21
1
2022 - 03 - 16
1
2021 - 11 - 12
1
2021 - 11 - 02
1
2021 - 10 - 07
1
2021 - 10 - 04
1
Crawled Time
00:00
3
00:20
1
01:00
3
02:00
1
08:00
2
10:00
3
11:00
5
12:00
7
13:00
2
14:30
1
15:00
1
15:20
1
15:30
1
16:00
2
17:00
3
18:00
6
19:00
3
21:00
2
22:00
2
23:00
2
Source
www.biospace.com
6
www.prnewswire.com
45
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Takeda pharmaceutical company limited
symbols :
Nvsef
save search
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.67%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.84%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.01%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-4.52%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.71%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.4%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.49%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.96%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
7.24%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
26.78%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-14.57%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.18%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.0%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.22%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.63%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.89%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.63%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.76%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
5.32%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.13%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
12.87%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-12.2%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.48%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.14%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.55%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.21%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-1.49%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.65%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.85%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-22.73%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.79%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.22%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.43%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-9.49%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-20.58%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.63%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$360.11
0.47%
0.47%
330K
|
Health Technology
|
-8.27%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.66%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-12.32%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.76%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
38.0%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-12.76%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.5%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.04%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.03%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
3.02%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-0.67%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-2.7%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.25%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.49%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-11.84%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.25%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-14.91%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
United States Endometrial Cancer Research Report 2023
Published:
2024-02-02
(Crawled : 10:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.93%
|
O:
0.21%
H:
0.49%
C:
-0.9%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-10.41%
|
O:
-0.5%
H:
0.26%
C:
-1.03%
report
cancer
research
Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published:
2024-01-26
(Crawled : 15:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-9.5%
|
O:
-0.27%
H:
0.38%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-11.8%
|
O:
0.29%
H:
0.15%
C:
-0.13%
SRPT
|
$115.53
-0.88%
-0.9%
640K
|
Health Technology
|
-3.67%
|
O:
0.69%
H:
0.12%
C:
-1.75%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-16.79%
|
O:
0.0%
H:
0.35%
C:
-0.88%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-13.32%
|
O:
0.1%
H:
0.47%
C:
0.39%
market
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-21.02%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.34%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-22.51%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-5.97%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
26.75%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.64%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.17%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
23.82%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-2.45%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
12.6%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.27%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.47%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.88%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published:
2023-11-06
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
17.51%
|
O:
0.41%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
22.15%
|
O:
0.11%
H:
0.33%
C:
-0.98%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
42.1%
|
O:
0.22%
H:
1.49%
C:
-0.33%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-3.43%
|
O:
0.44%
H:
0.22%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.97%
|
O:
0.24%
H:
0.18%
C:
0.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-2.48%
|
O:
0.18%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
14.26%
|
O:
0.55%
H:
0.3%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
12.24%
|
O:
-0.42%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.37%
|
O:
-1.32%
H:
0.0%
C:
0.0%
covid-19
Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting
Published:
2023-11-02
(Crawled : 18:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-3.0%
|
O:
1.03%
H:
0.73%
C:
0.58%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.11%
|
O:
-1.09%
H:
1.03%
C:
0.91%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
5.21%
|
O:
1.32%
H:
0.45%
C:
-1.19%
MOR
|
News
|
$17.96
-0.5%
-0.5%
180K
|
Health Technology
|
121.43%
|
O:
2.22%
H:
0.6%
C:
-9.4%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-3.72%
|
O:
-0.28%
H:
1.0%
C:
-0.46%
presentation
meeting
Global Antifibrinolytic Drugs Market Soars to $16.2 Billion in 2022, Driven by Rising Trauma Cases and Surgical Applications
Published:
2023-09-20
(Crawled : 00:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
13.87%
|
O:
-0.4%
H:
0.2%
C:
-1.52%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.72%
|
O:
-1.66%
H:
0.0%
C:
-0.56%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.9%
|
O:
-0.7%
H:
0.06%
C:
-0.75%
global
market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
11.2%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.04%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-29.52%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.18%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.61%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.59%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
60.42%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.48%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-4.43%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published:
2023-06-08
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-7.28%
|
O:
0.07%
H:
0.0%
C:
-1.7%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.25%
|
O:
1.32%
H:
0.0%
C:
-0.62%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.71%
|
O:
-0.62%
H:
0.88%
C:
0.81%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-4.2%
|
O:
1.26%
H:
1.08%
C:
0.91%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
15.69%
|
O:
0.41%
H:
0.68%
C:
0.64%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
66.44%
|
O:
-0.11%
H:
2.66%
C:
2.24%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.91%
|
O:
0.28%
H:
0.42%
C:
-0.05%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-20.66%
|
O:
0.39%
H:
0.15%
C:
-0.79%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-6.49%
|
O:
-0.23%
H:
1.83%
C:
1.52%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
21.55%
|
O:
0.0%
H:
0.28%
C:
-0.23%
metabolic
report
cancer
global
therapeutics
growth
market
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published:
2023-06-01
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-8.59%
|
O:
-0.56%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-7.79%
|
O:
-0.74%
H:
1.4%
C:
0.35%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.61%
|
O:
0.99%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.68%
|
O:
1.32%
H:
0.31%
C:
0.12%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-31.61%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-22.33%
|
O:
-1.84%
H:
1.62%
C:
1.33%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.83%
|
O:
1.03%
H:
0.84%
C:
0.82%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.35%
|
O:
0.37%
H:
1.34%
C:
1.14%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.84%
|
O:
1.05%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-5.89%
|
O:
0.11%
H:
0.69%
C:
-0.45%
report
global
therapeutics
growth
market
Global Addiction Treatment Market Report 2023: Sector to Reach $11.7 Billion by 2031 at a 6.1% CAGR
Published:
2023-05-26
(Crawled : 00:20)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
SYK
|
$325.43
-0.62%
0.0%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
report
reach
treatment
global
market
Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published:
2023-05-15
(Crawled : 17:00)
- prnewswire.com
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-32.3%
|
O:
0.24%
H:
0.66%
C:
0.66%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
7.89%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-19.17%
|
O:
0.61%
H:
0.3%
C:
0.24%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.51%
|
O:
0.2%
H:
0.13%
C:
-0.22%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
8.81%
|
O:
0.27%
H:
0.6%
C:
0.41%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.4%
|
O:
0.38%
H:
0.0%
C:
0.0%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-31.16%
|
O:
0.38%
H:
0.91%
C:
0.69%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
15.45%
|
O:
0.14%
H:
0.28%
C:
0.11%
report
cancer
global
therapy
growth
market
Global Gaucher's Disease Treatment Market Research Report 2023: Emerging Therapies, Clinical Trials, Treatments, Current Scenario Evaluation, Patient Profile
Published:
2023-05-10
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
8.88%
|
O:
0.92%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-22.03%
|
O:
-1.83%
H:
0.12%
C:
-3.06%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.95%
|
O:
-0.4%
H:
0.34%
C:
0.19%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.5%
|
O:
0.11%
H:
0.22%
C:
-0.52%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.08%
|
O:
-0.57%
H:
0.37%
C:
-0.01%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.42%
|
O:
-0.28%
H:
0.0%
C:
0.0%
disease
report
treatment
research
global
market
Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report 2023: New Drug Launches and Growing Awareness Fuels $32 Billion Industry
Published:
2023-04-27
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.12%
|
O:
0.23%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-21.47%
|
O:
-1.13%
H:
0.3%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.08%
|
O:
-0.79%
H:
0.89%
C:
0.72%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.26%
|
O:
-0.12%
H:
0.58%
C:
0.55%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
10.39%
|
O:
-0.25%
H:
0.97%
C:
0.31%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
86.07%
|
O:
1.96%
H:
1.59%
C:
-0.54%
drug
report
treatment
global
growing
market
Ulcerative Colitis Drug Global Market Report 2022: Increasing Prevalence of Ulcerative Colitis and Inflammatory Bowel Diseases Bolsters Sector
Published:
2023-04-07
(Crawled : 11:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
drug
report
global
market
Opioid Induced Constipation (OIC) Drugs Market to Reach USD 1.79 billion, Globally, by 2031 at 4.9% CAGR: Allied Market Research
Published:
2023-02-24
(Crawled : 16:00)
- prnewswire.com
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
-95.41%
|
O:
6.42%
H:
0.04%
C:
-4.87%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.08%
|
O:
-1.25%
H:
0.59%
C:
0.59%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.31%
|
O:
-2.47%
H:
0.0%
C:
-0.32%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
9.04%
|
O:
-0.25%
H:
0.03%
C:
-0.81%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-11.78%
|
O:
-0.81%
H:
1.28%
C:
-2.05%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.71%
|
O:
-0.98%
H:
0.16%
C:
-0.55%
research
opioid
market
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.